天然产物研究与开发 ›› 2023, Vol. 35 ›› Issue (4): 648-655.doi: 10.16333/j.1001-6880.2023.4.012

• 开发研究 • 上一篇    下一篇

肉苁蓉苯乙醇苷对慢性高原病模型大鼠的治疗作用及机制研究

曙丽盼·木拉提,江荣松,张伟怡*,陶义存*   

  1. 新疆医科大学 药学院,乌鲁木齐 830000
  • 出版日期:2023-04-24 发布日期:2023-04-24
  • 基金资助:
    新疆省天然药物有效成分与释放技术重点实验室基金(XJDX1713)

Therapeutic effect and mechanism of cistanche phenylethanoid glycosides on chronic altitude disease model rats

SHULIPAN·Mulati,JIANG Rong-song,ZHANG Wei-yi*,TAO Yi-cun*   

  1. School of Pharmacy,Xinjiang Medical University,Urumqi 830000,China
  • Online:2023-04-24 Published:2023-04-24

摘要: 通过测定血液红细胞数、血红蛋白含量、红细胞比容、肺组织匀浆液中内皮素-1(endothelin-1,ET-1)、一氧化氮(nitric oxide,NO)含量、一氧化氮合酶(nitric oxide synthase,NOS)活力以及过氧化物酶体增殖物激活受体α(peroxisome proliferator-activated receptor alpha,PPAR-α)、缺氧诱导因子1α(hypoxia-inducible factor 1,HIF-1α)及血管内皮生长因子(vascular endothelial growth factor,VEGF)mRNA水平和蛋白表达的变化,探究肉苁蓉苯乙醇苷(phenylethanoid glycosides from cistanche,PhGCs)对慢性高原病(chronic mountain sickness,CMS)模型大鼠的治疗作用及作用机制。结果显示,与模型组大鼠相比,PhGCs和大花红景天能降低CMS大鼠右心室肥厚和ET-1含量、升高NO含量和总一氧化氮合酶(total nitric oxide synthase,T-NOS)、内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)、诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)酶活力,下调肺组织HIF-1α及VEGF蛋白的表达,上调PPAR-α蛋白的表达,同时降低肺组织中HIF-1α的mRNA水平;此外,大鼠血液红细胞数、血红蛋白含量及红细胞比容无明显变化。该研究表明PhGCs可能是通过抑制HIF通路、激活NO通路发挥作用。

关键词: 肉苁蓉苯乙醇苷, 慢性高原病, 低氧诱导因子通路

Abstract:

To observe the therapeutic effect and mechanism of phenylethanoid glycosides from cistanche (PhGCs) on chronic mountain sickness (CMS) model rats,the red blood corpuscle,hemoglobin,hematocrit value,endothelin-1 (ET-1),and nitric oxide (NO) content,nitric oxide synthase (NOS) enzyme activity,the expression and mRNA levels of peroxisome proliferator-activated receptor alpha(PPAR-α),hypoxia-inducible factor 1(HIF-1α),vascular endothelial growth factor (VEGF) in the homogenate of lung tissue were measured.Results showed that PhGCs and Rhodiola rosea can reduce the right ventricular hypertrophy and the ET-1 content,increase the NO content and the enzyme activity of total nitric oxide synthase (T-NOS),endothelial nitric oxide synthase (eNOS),inducible nitric oxide synthase (iNOS),down-regulate the expression and mRNA levels of HIF-1α and VEGF,up-regulate the expression of PPAR-α in the homogenate of lung tissue of CMS;furthermore,the red blood corpuscle,hemoglobin and hematocrit value had no significant changes compared with rats in model group.In this study,it was confirmed that PhGCs inhibit HIF pathways and activate NO pathways.

Key words: phenylethanoid glycosides from cistanche, chronic mountain sickness, hypoxia-inducible factor pathway

中图分类号:  R961.1